simplethread-users Mailing List for Simple Java Thread Management (Page 2)

SourceForge Headquarters 225 Broadway Suite 1600 San Diego, CA 92101 +1 (858) 422-6466

AFTER-HOURS TRADING - BREAKING NEWS

Get Quote - http://quote.money.cnn.com/quote/quote?symbols=3Dhtds

Hard to Treat Diseases Incorporated - HTDS - Announces: Receipt of Tuberci=
n Toxicity Study and Formation of Scientific Advisory Panel - Wednesday De=
cember 3, 8:04 pm ET 

DELRAY BEACH, Fla.--(BUSINESS WIRE)--Dec. 3, 2003--Hard to Treat Diseases =
Incorporated (Pink Sheets: HTDS) announces today that the spokesperson for=
 the independent medical group conducting the testing for HTTD (HTDS) has =
forwarded the formal Testing Results of Tubercin=AE's Toxicity Trials to H=
TTD.

Tubercin of five different concentrations was administered to five groups =
of mice. A pathologist at the University of Oklahoma Health Science Center=
 performed autopsies. The mice were randomized and only the control mouse =
was known to the pathologist, as stated in the cover letter of the Patholo=
gy Report.

The report concludes, "All tissues evaluated, visceral organs and the brai=
n were essentially normal in appearance." "The importance of this report i=
s even better than I expected," stated the spokesperson for the medical gr=
oup. "As the testing continues and if the results are similar to those of =
Chemotherapy and or radiation with no harmful side effects, Tubercin has e=
normous potential for the treatment of cancer and the immune system."

The President and CEO of HTTD, Mr. Colm J. King is in the process of formi=
ng a Scientific Advisory Panel with leading Oncologists and Immunologists =
from prestigious institutions in the U.S. The panel will review the report=
s and results of Tubercin=AE's findings and will report back to Mr. King w=
ith the ongoing reports in layman language for the shareholders.

"We are continuing to receive promising results regarding Tubercin=AE and =
we're looking forward to additional positive results in the near future," =
stated Mr. King. "These tests prove that Tubercin=AE is non-toxic and is t=
he first step on the way to human clinical trials as well as the first pos=
itive breakthrough conducted in the United States with an independent medi=
cal group for Tubercin=AE. 

Operating out of Delray Beach, Florida, Hard to Treat Diseases Incorporate=
d ("HTTD") holds the international marketing rights, except South Korea, t=
o Tubercin=AE, a patented immunostimulant developed for combating Cancer u=
nder medical patent (US Patent 6,274,356). The unique properties unlike ot=
her cancer products are clearly stated in the abstract summary of the pate=
nt... "A carbohydrate complex, which is a mixture of low molecular-weight =
polysaccharides of an arabinomannan structure extracted from Mycobacterium=
 tuberculosis, is highly effective in treating various cancer patients wit=
hout incurring any adverse side effects." 

Statements in this press release that are not historical facts are forward=
-looking statements within the meaning of the Securities Act of 1933, as a=
mended. Those statements include statements regarding the intent, belief o=
r current expectations of the Company and its management. Such statements =
reflect management's current views, are based on certain assumptions and i=
nvolve risks and uncertainties. Actual results, events, or performance may=
 differ materially from the above forward-looking statements due to a numb=
er of important factors, and will be dependent upon a variety of factors, =
including, but not limited to, our ability to obtain additional financing =
and access funds from our existing financing arrangements that will allow =
us to continue our current and future operations and whether demand for ou=
r product and testing service in domestic and international markets will c=
ontinue to expand. The Company undertakes no obligation to publicly update=
 these forward-looking statements to reflect events or circumstances that =
occur after the date hereof or to reflect any change in the Company's expe=
ctations with regard to these forward-looking statements or the occurrence=
 of unanticipated events.

tq dwtcwhdlulhzxhi ntplh hlrvkpzq uqc

2002	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct (2)	Nov	Dec
2003	Jan	Feb	Mar	Apr	May	Jun	Jul (1)	Aug	Sep	Oct	Nov (18)	Dec (19)
2004	Jan (3)	Feb (2)	Mar (3)	Apr (1)	May (1)	Jun	Jul	Aug (2)	Sep	Oct	Nov	Dec
2005	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct (1)	Nov (2)	Dec
2006	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov (1)	Dec (2)
2007	Jan	Feb (1)	Mar	Apr	May	Jun (1)	Jul	Aug	Sep	Oct	Nov (1)	Dec (1)
2008	Jan	Feb	Mar (3)	Apr	May	Jun	Jul (1)	Aug (2)	Sep (1)	Oct (1)	Nov	Dec (1)
2009	Jan (2)	Feb	Mar	Apr	May (4)	Jun (5)	Jul	Aug	Sep (1)	Oct	Nov	Dec (1)
2010	Jan	Feb	Mar	Apr (1)	May	Jun	Jul	Aug (1)	Sep	Oct	Nov	Dec
2011	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec (1)
2012	Jan (1)	Feb	Mar	Apr	May	Jun	Jul (2)	Aug (1)	Sep (1)	Oct	Nov	Dec
2015	Jan	Feb	Mar (1)	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec

simplethread-users Mailing List for Simple Java Thread Management (Page 2)

simplethread-users — Users list